UK Companies House feature
QUALASEPT LIMITED
Profile
- Company number
- 05548345
- Status
- Active
- Incorporation
- 2005-08-30
- Last accounts made up
- 2023-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Significant events
- “The Qualasept Holdings Ltd Group (Qualasept Holdings Limited and its wholly owned subsidiaries), including Qualasept Limited, was purchased by Integrated Clinical Oncology Network Pty Ltd (ICON Group) in August 2024, which operates integrated cancer care centres throughout Australia, South East Asia and the UK.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MIDDLETON, Mark Geoffrey | Director | 2025-02-01 | Jul 1973 | Australian |
| MUIR, Ian Stuart | Director | 2022-04-05 | Jan 1966 | British |
| ROBINSON, Andrew, Mr. | Director | 2023-08-01 | Aug 1972 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| PORTER, Lynette Anne | Secretary | 2005-09-01 | 2009-09-04 |
| WHITE, Victoria | Secretary | 2017-07-26 | 2019-01-14 |
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 2005-08-30 | 2005-08-30 |
| ALLEN, Peter George | Director | 2023-08-01 | 2024-08-01 |
| FOUNTAIN, Christopher James | Director | 2016-11-21 | 2022-03-31 |
| RODERICK, Mark Edward | Director | 2019-06-18 | 2022-04-14 |
| SLADE, David, Mr. | Director | 2024-08-01 | 2025-02-01 |
| WASTNAGE, Richard John | Director | 2006-04-08 | 2024-08-01 |
| WATT, Christopher Dean | Director | 2005-09-01 | 2024-08-01 |
| WATT, Maria Ann | Director | 2006-04-08 | 2018-02-20 |
| COMPANY DIRECTORS LIMITED | Corporate Nominee Director | 2005-08-30 | 2005-08-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Qualasept Pharmaxo Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 102 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-08-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-03-03 | TM01 | officers | termination director company with name termination date |
| 2025-03-03 | AP01 | officers | appoint person director company with name date |
| 2025-02-06 | AA | accounts | accounts with accounts type full |
| 2024-10-23 | AA01 | accounts | change account reference date company current extended |
| 2024-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-08-12 | TM01 | officers | termination director company with name termination date |
| 2024-08-12 | TM01 | officers | termination director company with name termination date |
| 2024-08-12 | TM01 | officers | termination director company with name termination date |
| 2024-08-12 | AP01 | officers | appoint person director company with name date |
| 2024-01-04 | AA | accounts | accounts with accounts type full |
| 2023-10-02 | AP01 | officers | appoint person director company with name date |
| 2023-10-02 | AP01 | officers | appoint person director company with name date |
| 2023-08-16 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-10-07 | AA | accounts | accounts with accounts type full |
| 2022-08-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-04-14 | TM01 | officers | termination director company with name termination date |
| 2022-04-08 | AP01 | officers | appoint person director company with name date |
| 2022-04-07 | TM01 | officers | termination director company with name termination date |
| 2022-02-02 | AA | accounts | accounts with accounts type full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.